Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year
HIV prevention services have been heavily affected by the pause on the US President’s Emergency Plan for Aids in the country, with remote mobile clinics that served hard-to-reach people now closed
The least the Trump administration could have done was provide ample warning that it was going to cut aid
Africa’s first locally made HIV treatment is more than a milestone, it’s a political, economic and moral turning point in the fight for health sovereignty
The US president’s cutting of financial support has cut life-saving treatment for many in SA
A federal judge has enforced a temporary restraining order blocking Donald Trump from freezing federal grants
Such programmes still qualify for a limited waiver, which will expire towards the end of April, but only for approved activities